According to a recent Washington Examiner article, one third of the US population suffers from chronic pain. Per the same article, 90 percent of doctors practicing medicine in America today do not know how to treat chronic pain. In 2015, 33 thousand lives were lost to opioid-related causes, and 45 percent of those deaths involved a prescription.
Not surprisingly, recently President Trump has declared Opioid Epidemic a Public Health Crisis.
Electronic neurostimulators with little or no side effects can be the answer to many problem, yet, surprisingly less than 100 thousand chronic pain sufferers can receive Spinal Cord Stimulation (SCS) per year.
New advanced neurostimulation devices, including the ones that can be fully programmed for customized personal care can help combat the opioid crises quickly and affordably. Further, programmable neurostimulators promise to accelerate medical research in areas of other neurological disorders.
The bottom line is, with the fully programmable neurostimulators, the solution to opioid crisis and new advanced therapies for many neurological disorders are much closer than we think.
Lone Star NeuroMODULATION
LSN is targeting unmet clinical needs by creating disruptive device platforms that offer promising solutions for lowering costs, realizing higher returns and effectively addressing more therapeutic indications if adopted for medical applications.